Osaic Holdings’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.95K Buy
6,802
+1,071
+19% +$1.37K ﹤0.01% 6434
2025
Q4
$8.76K Buy
5,731
+1,536
+37% +$2.66K ﹤0.01% 6425
2025
Q3
$7.23K Buy
4,195
+1,000
+31% +$3.18K ﹤0.01% 6557
2025
Q2
$10.5K Sell
3,195
-13
-0.4% -$48 ﹤0.01% 6120
2025
Q1
$8.95K Buy
3,208
+3,032
+1,723% +$19.8K ﹤0.01% 5848
2024
Q4
$3.06K Sell
176
-45
-20% -$769 ﹤0.01% 6436
2024
Q3
$5.99K Buy
221
+33
+18% +$1.03K ﹤0.01% 6115
2024
Q2
$7.66K Sell
188
-814
-81% -$44.7K ﹤0.01% 5945
2024
Q1
$66.7K Buy
1,002
+878
+708% +$65.5K ﹤0.01% 4526
2023
Q4
$14K Buy
124
+18
+17% +$1.88K ﹤0.01% 5665
2023
Q3
$19.2K Buy
106
+3
+3% +$786 ﹤0.01% 5584
2023
Q2
$37.6K Buy
103
+5
+5% +$2.26K ﹤0.01% 5124
2023
Q1
$65K Sell
98
-5
-5% -$4.44K ﹤0.01% 4783
2022
Q4
$88.3K Buy
103
+21
+26% +$26.4K ﹤0.01% 4534
2022
Q3
$90K Sell
82
-11
-12% -$14.5K ﹤0.01% 4462
2022
Q2
$76K Sell
93
-325
-78% -$334K ﹤0.01% 4628
2022
Q1
$650K Buy
418
+317
+314% +$428K ﹤0.01% 2972
2021
Q4
$181K Sell
101
-8
-7% -$21.4K ﹤0.01% 4042
2021
Q3
$361K Buy
109
+41
+60% +$143K ﹤0.01% 3360
2021
Q2
$299K Buy
68
+8
+13% +$31.6K ﹤0.01% 3518
2021
Q1
$291K Buy
60
+43
+253% +$242K ﹤0.01% 3406
2020
Q4
$31K Buy
+17
New +$6.35K ﹤0.01% 4886
2020
Q3
Sell
-8
Closed -$3K 6208
2020
Q2
$3K Buy
+8
New +$2.01K ﹤0.01% 5633

Other funds holding BNGO

Osaic Holdings's BNGO Position: Q1 2026 in Review

Osaic Holdings increased its Bionano Genomics (BNGO) stake by 19% in Q1 2026, buying an estimated $1.37K and bringing the position to 6,802 shares worth $7.95K. The position accounts for ﹤0.01% of the portfolio, ranked #6434.

Osaic Holdings first reported a position in BNGO in Q2 2020 and has held it in 23 quarters since. The position peaked at $650K in Q1 2022. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Osaic Holdings held 6,802 shares of Bionano Genomics worth $7.95K as of Q1 2026.
  • Osaic Holdings bought 1,071 Bionano Genomics shares in Q1 2026, an estimated $1.37K.
  • Bionano Genomics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6434 holding.
  • Osaic Holdings first reported a position in Bionano Genomics in Q2 2020 and has held it in 23 quarters since.
  • Osaic Holdings's Bionano Genomics position peaked at $650K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.